Improved Survival of Patients Hospitalized with Decompensated Heart Failure

Tal Hasin Integrated Heart Center, Shaare Zedek Medical Center, Jerusalem, Israel Tatyana Weitsman Integrated Heart Center, Shaare Zedek Medical Center, Jerusalem, Israel Chen Harush Integrated Heart Center, Shaare Zedek Medical Center, Jerusalem, Israel Rivka Farkash Integrated Heart Center, Shaare Zedek Medical Center, Jerusalem, Israel Yariv Gerber Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel Marc Klutstein Integrated Heart Center, Shaare Zedek Medical Center, Jerusalem, Israel Michael Glikson Integrated Heart Center, Shaare Zedek Medical Center, Jerusalem, Israel

Introduction

Patients hospitalized for heart failure (HF) have increased mortality. We investigated trends in outcome of hospitalized HF patients.

Methods

Patients hospitalized in cardiology with first HF decompensation were included and divided to four hospitalization periods: 11.2005-10.2008, 11.2008-10.2011, 11.2011-10.2014 and 11.2014-10.2016. A HF unit including inpatient and outpatient services was established during the last period. Mortality data were acquired from the national registry.

Results

Patient characteristics illustrate increased comorbidities and beta blocker use (Table). In-hospital mortality was 2.5%; 18% had unplanned 1 year re-hospitalizations without difference between periods. There was a significant decrease in 1 year mortality (figure). During the last period, follow-up in the new HF clinic was significantly associated with better survival, HR=0.39 95%CI[0.18-0.87];p=0.021 (adjusted for age, sex, hypertension, diabetes)

Conclusions

Outcomes of HF hospitalization are improving. Establishing a dedicated HF unit and clinic follow-up may have additive benefit.

Presentation

Tal Hasin

Rabin